What does DEMANapath do?

DEMANapath is a specialist medical practice in Rotselaar. Private Limited, started on 12 March 2020, 2 establishments.

What is the address of DEMANapath?

The registered office of DEMANapath is located at Hellichtstraat 128, 3110 Rotselaar.

Is DEMANapath still active?

Yes. According to the CBE (15 November 2026) DEMANapath is active, legal situation “Normale toestand”, started on 12 March 2020.

Is DEMANapath registered on Peppol?

Yes, DEMANapath is registered on the Peppol network with ID 0208:0745351661.

What is the enterprise number of DEMANapath?

The enterprise number of DEMANapath is BE0745351661.

When was DEMANapath founded?

DEMANapath was founded on 12 March 2020.

Who are the directors of DEMANapath?

According to the 2025 annual accounts, the directors of DEMANapath are: Frederik Deman.

Is DEMANapath a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 12 March 2020; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 2 establishments in the CBE; 1 events from the Belgian Official Gazette processed.

How much profit did DEMANapath make in 2025?

DEMANapath posted a profit after taxes of € 171,407 in financial year 2025.

What is the revenue of DEMANapath?

As a small company, DEMANapath is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 227,475.

Does DEMANapath have a website?

Yes, DEMANapath has a website at souriretandartsen.be.

DEMANapath (Private Limited) - Rotselaar - BE0745351661

Dossier DEMANapath, printed on 15 November 2026 from databakkes.be/en/0745351661/demanapath. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DEMANapath from Rotselaar, company number BE0745351661, closed financial year 2025 with a result of € 171,407 after tax. For that financial year DEMANapath recorded a gross margin of € 227,475 and equity of € 180,341. Compared with financial year 2024, the result moved from € 151,477 to € 171,407. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 31, 2026.

What it is worth Healthy

€ 180,341

▼ 39% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 171,407

▲ 13% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 111,473

▼ 35% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 287,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 48,012

▼ 24% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 1 years to go

€ 8,596

▼ 56% vs 2024

€ 7,931 is repaid this year. At this pace the long-term loan is gone in ≈ 1 years.

Owed to suppliers

€ 3,452

▼ 22% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 3,237

▼ 31% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 115,820 Gross margin 2022: € 115,820 First fiscal year in the series	€ 168,091 Gross margin 2023: € 168,091 ▲ 45% vs 2022 (€ 115,820) Favourable step	€ 214,195 Gross margin 2024: € 214,195 ▲ 27% vs 2023 (€ 168,091) Favourable step	€ 227,475 Gross margin 2025: € 227,475 ▲ 6% vs 2024 (€ 214,195) Favourable step	▲ 6%
Profit after taxes	€ 71,697 Profit after taxes 2022: € 71,697 First fiscal year in the series	€ 105,318 Profit after taxes 2023: € 105,318 ▲ 47% vs 2022 (€ 71,697) Favourable step	€ 151,477 Profit after taxes 2024: € 151,477 ▲ 44% vs 2023 (€ 105,318) Favourable step	€ 171,407 Profit after taxes 2025: € 171,407 ▲ 13% vs 2024 (€ 151,477) Favourable step	▲ 13%
Equity	€ 190,140 Equity 2022: € 190,140 First fiscal year in the series	€ 295,457 Equity 2023: € 295,457 ▲ 55% vs 2022 (€ 190,140) Favourable step	€ 295,935 Equity 2024: € 295,935 Unchanged (€ 295,457) Favourable step	€ 180,341 Equity 2025: € 180,341 ▼ 39% vs 2024 (€ 295,935) Unfavourable step	▼ 39%
Total debts	€ 54,045 Total debts 2022: € 54,045 First fiscal year in the series	€ 41,689 Total debts 2023: € 41,689 ▼ 23% vs 2022 (€ 54,045) Favourable step	€ 180,722 Total debts 2024: € 180,722 ▲ € 139,032 vs 2023 (€ 41,689) Unfavourable step	€ 193,009 Total debts 2025: € 193,009 ▲ 7% vs 2024 (€ 180,722) Unfavourable step	▲ 7%
Cash	€ 133,416 Cash 2022: € 133,416 First fiscal year in the series	€ 170,522 Cash 2023: € 170,522 ▲ 28% vs 2022 (€ 133,416) Favourable step	€ 171,787 Cash 2024: € 171,787 ▲ 1% vs 2023 (€ 170,522) Favourable step	€ 111,473 Cash 2025: € 111,473 ▼ 35% vs 2024 (€ 171,787) Unfavourable step	▼ 35%
Retained profit	€ 188,790 Retained profit 2022: € 188,790 First fiscal year in the series	€ 294,107 Retained profit 2023: € 294,107 ▲ 56% vs 2022 (€ 188,790) Favourable step	€ 294,585 Retained profit 2024: € 294,585 Unchanged (€ 294,107) Favourable step	€ 178,991 Retained profit 2025: € 178,991 ▼ 39% vs 2024 (€ 294,585) Unfavourable step	▼ 39%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 151,000 Dividend 2024: € 151,000 Unchanged (€ 0) Unchanged	€ 287,000 Dividend 2025: € 287,000 ▲ 90% vs 2024 (€ 151,000) Unchanged	▲ 90%
Bank debt	€ 47,416 Bank debt 2022: € 47,416 First fiscal year in the series	€ 33,564 Bank debt 2023: € 33,564 ▼ 29% vs 2022 (€ 47,416) Favourable step	€ 19,576 Bank debt 2024: € 19,576 ▼ 42% vs 2023 (€ 33,564) Favourable step	€ 8,596 Bank debt 2025: € 8,596 ▼ 56% vs 2024 (€ 19,576) Favourable step	▼ 56%
Balance sheet total	€ 244,185 Balance sheet total 2022: € 244,185 First fiscal year in the series	€ 337,147 Balance sheet total 2023: € 337,147 ▲ 38% vs 2022 (€ 244,185) Unchanged	€ 476,656 Balance sheet total 2024: € 476,656 ▲ 41% vs 2023 (€ 337,147) Unchanged	€ 373,351 Balance sheet total 2025: € 373,351 ▼ 22% vs 2024 (€ 476,656) Unchanged	▼ 22%

By gross margin, DEMANapath ranks 6th of 18 companies with main activity “Activiteiten van medisch specialisten” in Rotselaar that publish figures (fiscal year 2025).

Key figures of DEMANapath, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

Ask about DEMANapath the way you would ask their accountant.

Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.

Connect ChatGPT or Claude for free

ChatGPT
Claude

Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.

What happened to DEMANapath?

What happened at DEMANapath in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 31, 2026 New annual accounts for financial year 2025: profit of € 171,407 (▲ 13% vs 2024). Source: NBB ↗
Aug 1, 2020 New establishment in Rotselaar. KBO
Aug 1, 2020 New establishment in Antwerpen. KBO
Mar 16, 2020 Incorporation, published in the Gazette. Source: Staatsblad ↗

In short

From € 71,697 profit in 2022 to € 171,407 profit in 2025.

Paid € 160,896 in corporate taxes since 2022.

Best year ever: 2025, with € 171,407 profit.

Paid out € 438,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Frederik Deman

DEMANapath

Behind DEMANapath is Frederik Deman.

Directors

According to the 2025 annual accounts

Frederik Deman

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Hellichtstraat 128

3110 Rotselaar

2.305.602.403

Lindendreef 1

2020 Antwerpen

Active since 1 August 2020

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Similar companies in Rotselaar

Same main activity (Activiteiten van medisch specialisten), 17 active companies in Rotselaar, largest first.

Dr. Kevin Punie

€ 503,219 gross margin · 2025

DR. K. MARIS

€ 325,874 gross margin · 2025

ROAN

€ 313,476 gross margin · 2025

Dr. Johan Debeuf

€ 251,004 gross margin · 2025

Dr. Joan Vlayen

€ 241,024 gross margin · 2025

Dokter Laurenz De Donder

€ 214,693 gross margin · 2025

All companies with this activity → Largest companies in Rotselaar →

Website

HTTPS souriretandartsen.be

Canonical: https://www.souriretandartsen.be

Technologies

Cookie ConsentGoogle AnalyticsNginxSwiperVue.jsjQuery

Hosting & Email

Email provider

Microsoft 365

Hosting

GOOGLE-CLOUD-PLATFORM - Google LLC, US

Website info

HTTPS Ja

Languages NL

Features

Contact page

Security

✓ HTTPS

✓ SPF

✓ DMARC

Shareholders according to the Official Gazette deeds

Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.

Incorporation

16 March 2020 Source: Deed ↗

DEMAN Frederik Elisabeth Marcel Maria(oprichter) 100%

Details

Company number

0745.351.661

VAT number

BE 0745.351.661

Registered office

Hellichtstraat 128, 3110 Rotselaar

Names & denominations

DEMANapath

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

12 March 2020

Peppol

Active · Active since 7 Oct 2026

Contact

souriretandartsen.be +32473751692

Activities · NACE

Activiteiten van medisch specialisten

Activiteiten van medische beeldvorming en medische laboratoria

Activiteiten van medische laboratoria

View on CBE Public ↗ Annual accounts (NBB) ↗

DEMANapath

Financials

Ask about DEMANapath the way you would ask their accountant.

What happened to DEMANapath?

Management

Directors

Establishments

Establishment units

Similar companies in Rotselaar

Website

Technologies

Hosting & Email

Website info

Features

Security

Shareholders according to the Official Gazette deeds

Details

Frequently asked questions